Clade I mpox appears to be spreading locally, San Francisco health officials say
The city has recorded 16 clade I cases since April, and more of them involve people who had not traveled abroad.
SAN FRANCISCO - Clade I mpox appears to be spreading in California and the U.S., the San Francisco Department of Public Health said in a health update published Nov. 20. A growing share of the city’s clade I cases involve people with no recent international travel or known link to a traveler, suggesting local acquisition, it says.
The city has recorded 16 clade I mpox cases from April through Nov. 12, the department said. Most people with clade I in the U.S. have had relatively mild illness and there have been no associated deaths, though officials are still learning if and how severity differs between clades.
What doctors are told
It asks clinicians to recommend the two-dose JYNNEOS vaccine, given 28 days apart, to people who would benefit. It says to assess mpox risk and vaccination status at all visits for men, trans, or nonbinary people who have sex with men, trans, or nonbinary people. The department does not recommend booster doses.
Both clades can start with flu-like symptoms such as fever and chills, the department said. It says testing, clinical management, prevention and reporting are the same for either clade, and there is no FDA-approved treatment for either.
Source: SFDPH Health Update: Community Transmission of Clade I Mpox in the United States, published Nov. 20, 2026.